PTK2 and neoplasm: It should be noted that in pancreatic ductal adenocarcinoma, PF-271 inhibit cell migration in tumour cells but had no effect on cell proliferation at doses 10 times higher than those required to inhibit FAK catalytic activity and migration/invasion processes [119].